Evotec SE (EVO) Fundamentals

Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.
SHARE INFORMATION
Market Cap$ 5,057,306,823
Shares Outstanding353,905,306
Float353,905,306
Percent Float100.0%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 628,695,087
Latest Fiscal EPS$ 0.74
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions46
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months154,142
Institutional Holdings Percent2.5%
Institutional Sold Previous 3 Months1,616,556
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 35.37
52 Week Low$ 10.60
52 Week High Change$ -49.80
21 Day Moving Average$ 13.1057
21 Day Extended Moving Average$ 13.3549
50 Day Moving Average$ 13.0124
50 Day Extended Moving Average$ 13.1718
200 Day Moving Average$ 16.9939
200 Day Extended Moving Average$ 16.7516
10 Day Average Volume38,527
20 Day Average Volume31,028
30 Day Average Volume28,201
50 Day Average Volume28,191
Alpha0.002910
Beta1.1267
Standard Deviation0.137044
R20.169081
7 Day Price Change$ 1.62
7 Day Percent Change12.79%
21 Day Price Change$ 1.93
21 Day Percent Change15.61%
30 Day Price Change$ 1.81
30 Day Percent Change14.5%
Month to Date Price Change$ 1.62
Month to Date Percent Change12.79%
Quarter to Date Price Change$ 2.31
Quarter to Date Percent Change19.28%
180 Day Price Change$ -3.18
180 Day Percent Change-18.2%
200 Day Price Change$ -5.78
200 Day Percent Change-28.8%
Year to Date Price Change$ -9.46
Year to Date Percent Change-39.83%

Evotec SE (EVO) Key Ratios

PROFITABILITY
EBIT Margin19.2%
EBITDA Margin19.2%
Pre-Tax Profit Margin10.5%
Profit Margin Count5.78%
Gross Margin23.6%
Profit Margin TOT5.78%
INCOME STATEMENTS
Revenue$ 520,225,719
Revenue Per Share$ 1.47
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.70
Total Debt To Equity0.40
Int Coverage11.30
Current Ratio3.10
Leverage Ratio1.60
Quick Ratio2.90
Long Term Debt To Capital0.26
VALUATION MEASURES
PE Ratio44.10
Enterprise Value$ 4,681,679,325
Price to Sales9.7214
Price to Free Cash134.10
PE High Last 5 Years1,095.50
Price To Book4.00
Price To Cash Flow27.10
PE Low Last 5 Years30.90
Price to Tangible Book4.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.60
Invoice Turnover22.90
Assets Turnover0.10
Return Assets4.76
Return on Equity8.52
Return on Capital6.14

Evotec SE (EVO) Profile

PROFILE INFO
Issue TypeCS
SEC TypeDR
AuditorBDO AG Wirtschaftsprüfungsgesellschaft
CEOWerner Lanthaler
Emplyoees4354
Last AuditUE
CIK0001412558
IndustryDrug Manufacturers
SectorHealthcare
NAICS-
CONTACT INFO
AddressEssener Bogen 7
Manfred Eigen Campus
Hamburg, 22419
Websitehttps://www.evotec.com
Facsimile+49 4056081222
Telephone+49 40560810
Emailwerner.lanthaler@evotec.com


Your Recent History
NASDAQ
EVO
Evotec
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.